Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer

Author(s): S. Rekhraj, J. Kinross, S. Prabhudesai, A. Darzi, P. Ziprin

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 7 , Issue 5 , 2007

Become EABM
Become Reviewer

Abstract:

Recent evidence has suggested improved outcomes following incorporation of intraperitoneal chemotherapy administration with intravenous systemic chemotherapy as first-line treatment of small volume residual epithelial ovarian cancer. This review focuses on the mechanism of actions of the chemotherapeutic drugs and reviews the possible reasons for the superior outcomes of intraperitoneal chemotherapy.

Keywords: Intraperitoneal chemotherapy, cisplatin, carboplatin, paclitaxel, ovarian cancer management

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 5
Year: 2007
Page: [511 - 519]
Pages: 9
DOI: 10.2174/138955707780619644
Price: $65

Article Metrics

PDF: 2